Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system (Q33280446)

25 July 2017

title

Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system (English)

1 reference

25 July 2017

main subject

hepatocellular carcinoma

1 reference

Sherri Oliver Stuver

9

0 references

author name string

Shuji Kanmura

1

1 reference

25 July 2017

Hirofumi Uto

2

1 reference

25 July 2017

Kazunori Kusumoto

3

1 reference

25 July 2017

Yoichi Ishida

4

1 reference

25 July 2017

Satoru Hasuike

5

1 reference

25 July 2017

Kenji Nagata

6

1 reference

25 July 2017

Katsuhiro Hayashi

7

1 reference

25 July 2017

Akio Ido

8

1 reference

25 July 2017

Hirohito Tsubouchi

10

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

45

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

948-956

1 reference

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy

25 July 2017

cites work

1 reference

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

21 January 2018

1 reference

A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma

21 January 2018

1 reference

New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology

21 January 2018

1 reference

Rising incidence of hepatocellular carcinoma in the United States

21 January 2018

1 reference

7 January 2021

Prevention of hepatitis C virus-related hepatocellular carcinoma

1 reference

7 January 2021

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

7 January 2021

The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin

1 reference

7 January 2021

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

1 reference

7 January 2021

Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma

1 reference

7 January 2021

Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein1

1 reference

7 January 2021

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

1 reference

7 January 2021

Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan

1 reference

7 January 2021

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

1 reference

7 January 2021

Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture

1 reference

7 January 2021

Selection bias in gene extraction on the basis of microarray gene-expression data

1 reference

7 January 2021

Proteome analysis of hepatocellular carcinoma

1 reference

7 January 2021

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

7 January 2021

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma

1 reference

7 January 2021

The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma

1 reference

7 January 2021

Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus

1 reference

7 January 2021

A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma

1 reference

7 January 2021

Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry.

1 reference

7 January 2021

Characterization of the low molecular weight human serum proteome

1 reference

7 January 2021

Proteomics for hepatocellular carcinoma marker discovery

1 reference

7 January 2021

Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.

1 reference

7 January 2021

Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology

1 reference

7 January 2021

Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons

1 reference

7 January 2021

Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes

1 reference

7 January 2021

Alphafetoprotein: an obituary

1 reference

7 January 2021

Transforming growth factor-beta1 as a useful serologic marker of small hepatocellular carcinoma

1 reference

7 January 2021

Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma

1 reference

7 January 2021

Differential gene expression between chronic hepatitis B and C hepatic lesion

1 reference

7 January 2021

Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21598

1 reference

25 July 2017

1 reference